Sort   by:  
 Page size 
UnknownAtaluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial.
Not available
S-EPMC4154311 | biostudies-literature
UnknownInterleukin (IL)-1/IL-6-Inhibitor-Associated Drug Reaction With Eosinophilia and Systemic Symptoms (DReSS) in Systemic Inflammatory Illnesses.
Not available
S-EPMC11560592 | biostudies-literature
UnknownHeterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype.
Not available
S-EPMC4920021 | biostudies-literature
UnknownHLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis.
Not available
S-EPMC4702958 | biostudies-literature
Sort   by:  
 Page size